Long-Term Follow-Up after Prostatectomy for Prostate Cancer and the Need for Active Monitoring

Table 4

Risk for biochemical (PSA) failure based on risk groups.

Risk groups		# patients (%)
Low	No or one intermediate-risk factor	373 (64%)
Intermediate	Two intermediate-risk factors	112 (19%)
High	Gleason >7 or PSA >20 or all 3 intermediate-risk factors	96 (17%)

Low-risk factors: Gleason <7, PSA <10 ng/ml, and mar/epe negative. Intermediate-risk factors: Gleason 7, PSA 10–20 ng/ml, and mar/epe positive. High-risk factors: Gleason 8–10 and PSA >20 ng/ml.